PURPOSE
Sleep-related symptoms in head and neck cancer are poorly characterized and often under-recognized. We examined symptom trajectories, prevalence of moderate/severe symptoms, and associations between severe sleep-related patient-reported symptoms and overall survival (OS) in oropharyngeal cancer (OPC) patients r...
G. Carevic, W. Floyd, Rishabh Gaur et al.· Radiotherapy and Oncology· 0 citations
Introduction Trastuzumab deruxtecan (T-DXd) has transformed treatment for HER2-expressing malignancies, yet pneumonitis remains a potentially fatal toxicity. Most pneumonitis data derive from breast cancer cohorts, but risk factors and outcomes in non-breast solid organ tumors are poorly characterized. Materials and Me...
A. Attia, Jose Carlos Tuesta Delgado, Alexia Dayan Lecaros Zavalla et al.· Journal of Immunotherapy and...· 0 citations
This position article synthesizes key barriers in ICI therapy while highlighting emerging opportunities to refine patient selection, improve safety, and enhance therapeutic durability, position the field to move beyond the current plateau toward a more precise, effective, and patient-centered era of immuno-oncology.
Joud Hajjar, B. Stephen, A. Aaroe et al.· Journal of Immunotherapy and...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.